Both in Biotechnology
Revolution Medicines vs Moderna
Over the past year RVMD returned +241.0% and MRNA returned +987.9%; their daily moves had a correlation of 0.12.
RVMD +241.0% MRNA +987.9%Growth of $1, one year, split-adjusted
| Metric | RVMD | MRNA |
|---|---|---|
| Price | $199.70 | $258.38 |
| Market cap | $42.80B | $103.15B |
| Today | +2.82% | +13.11% |
| 1 month | −0.1% | +37.8% |
| 6 months | +32.2% | +429.6% |
| Year to date | +150.7% | +776.2% |
| 1 year | +236.6% | +937.3% |
| Revenue growth (YoY) | — | +2.1% |
| Gross margin | — | 35.9% |
| Net margin | — | −539.3% |
| P/E (TTM) | — | — |
| Price / sales | — | 46.3× |
| Net cash | $3.45B | $4.54B |
| Dividend yield | — | — |
| Volatility (60d) | 39.9% | 231.0% |
| Short % of float | 6.4% | 9.0% |
| Next earnings | — | Nov 6, 2026 |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).